Home/Filings/4/0001209191-22-021021
4//SEC Filing

Sanford Svai S 4

Accession 0001209191-22-021021

CIK 0001856725other

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 9:08 PM ET

Size

7.2 KB

Accession

0001209191-22-021021

Insider Transaction Report

Form 4
Period: 2022-03-22
Sanford Svai S
Chief Financial Officer
Transactions
  • Award

    Class A Common Stock

    2022-03-22+32,900139,100 total
  • Award

    Stock Option (Right to Buy)

    2022-03-22+100,000100,000 total
    Exercise: $13.21Exp: 2032-03-21Class A Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]The shares subject to the restricted stock unit grant vest as follows: 25% of the RSUs shall vest yearly over four years from March 22, 2022.
  • [F2]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 22, 2022.

Issuer

Rani Therapeutics Holdings, Inc.

CIK 0001856725

Entity typeother

Related Parties

1
  • filerCIK 0001591411

Filing Metadata

Form type
4
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 9:08 PM ET
Size
7.2 KB